Neuroprotective effects of riluzole in early phase Parkinson's disease on clinically relevant parameters in the marmoset MPTP model

P.S. Verhave, M.J. Jongsma, R.M. Berg, R.A. Vanwersch, A.B. Smit, I.H.C.H.M. Philippens

Research output: Contribution to JournalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Neuroprotective effects of riluzole in early phase Parkinson's disease on clinically relevant parameters in the marmoset MPTP model'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience